Eloxx Pharmaceuticals, Inc.

GEODE CAPITAL MANAGEMENT, LLC ELOX

Report date

9/30/2022

Quarter

2022 Q3

Filed

11/14/2022

Shares

807,678

Value ($000)

137

Weight

0.0%

2019 Q4 - 2022 Q3 (12 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2022 Q3	11/14/2022	137	0.0%	807,678	9/30/2022
2022 Q2	8/12/2022	214	0.0%	802,413	6/30/2022
2022 Q1	5/13/2022	448	0.0%	800,333	3/31/2022
2021 Q4	2/11/2022	558	0.0%	798,058	12/31/2021
2021 Q3	11/12/2021	1,259	0.0%	772,836	9/30/2021
2021 Q2	8/13/2021	1,049	0.0%	527,307	6/30/2021
2021 Q1	5/12/2021	1,473	0.0%	443,810	3/31/2021
2020 Q4	2/12/2021	1,670	0.0%	419,745	12/31/2020
2020 Q3	11/13/2020	1,095	0.0%	416,499	9/30/2020
2020 Q2	8/13/2020	1,202	0.0%	396,993	6/30/2020
2020 Q1	5/14/2020	755	0.0%	385,261	3/31/2020
2019 Q4	2/13/2020	2,547	0.0%	346,152	12/31/2019